Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Franciszek Saczewski & Łukasz Balewski. (2009) Biological activities of guanidine compounds. Expert Opinion on Therapeutic Patents 19:10, pages 1417-1448.
Read now
Read now
Steven Rosenberg. (2001) New developments in the urokinase-type plasminogen activator system. Expert Opinion on Therapeutic Targets 5:6, pages 711-722.
Read now
Read now
Articles from other publishers (5)
Vincent de Groot. 2007. Prodrugs. Prodrugs
447
506
.
Buddy Setyono-Han, Jörg Stürzebecher, Wolfgang A. Schmalix, Bernd Muehlenweg, Anieta M. Sieuwerts, Mieke Timmermans, Viktor Magdolen, Manfred Schmitt, Jan G. M. Klijn & John A. Foekens. (2017) Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1. Thrombosis and Haemostasis 93:04, pages 779-786.
Crossref
Crossref
Marion E. Meijer-van Gelder, Maxime P. Look, Harry A. Peters, Manfred Schmitt, Nils Brünner, Nadia Harbeck, Jan G. M. Klijn & John A. Foekens. (2004) Urokinase-Type Plasminogen Activator System in Breast Cancer. Cancer Research 64:13, pages 4563-4568.
Crossref
Crossref
Viktor Magdolen, Achim Krüger, Sumito Sato, Jutta Nagel, Stefan Sperl, Ute Reuning, Peter Rettenberger, Ulla Magdolen & Manfred Schmitt. 2003. Molecular Staging of Cancer. Molecular Staging of Cancer
43
63
.
M. P. Look, W. L. J. van Putten, M. J. Duffy, N. Harbeck, I. J. Christensen, C. Thomssen, R. Kates, F. Spyratos, M. Ferno, S. Eppenberger-Castori, C. G. J. F. Sweep, K. Ulm, J.-P. Peyrat, P.-M. Martin, H. Magdelenat, N. Brunner, C. Duggan, B. W. Lisboa, P.-O. Bendahl, V. Quillien, A. Daver, G. Ricolleau, M. E. Meijer-van Gelder, P. Manders, W. E. Fiets, M. A. Blankenstein, P. Broet, S. Romain, G. Daxenbichler, G. Windbichler, T. Cufer, S. Borstnar, W. Kueng, L. V. A. M. Beex, J. G. M. Klijn, N. O'Higgins, U. Eppenberger, F. Janicke, M. Schmitt & J. A. Foekens. (2002) Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients. JNCI Journal of the National Cancer Institute 94:2, pages 116-128.
Crossref
Crossref